PubMed · 1999 · 144 citations · 42 references
Life SciencesImmunologyOncologyCancer ImmunologyImmunotherapyTumor ImmunologyAntitumor T Cell ResponsesCancer ImmunotherapyCytokines In Tumor ImmunityT Cell BiologyT Cell Responses To TumorsTumor-infiltrating LymphocytesCytokine-mediated T Cell ActivationHomeostatic CytokinesRegulatory T Cell DepletionT Cell-based ImmunotherapyTherapeutic Growth InhibitionTolerogenic Cytokines
It has been demonstrated that gamma delta T cells accumulating in early tumor lesions and those purified from spleen cells of tumor-bearing mice attenuate the activity of CTLs and NK cells. We, therefore, investigated whether depletion of gamma delta T cells from early lesions of tumors results in restoration of CTL and NK cell activities and subsequent regression of tumors. A daunomycin-conjugated anti-gamma delta TCR mAb UC7-13D5 (Dau-UC7) was prepared to efficiently deplete gamma delta T cells. An in vitro study revealed that Dau-UC7 specifically lysed gamma delta TCR+ cells and effectively inhibited splenic gamma delta T cells from tumor-bearing mice to produce cytotoxic cell-suppressive factors. Furthermore, intralesional injections of Dau-UC7 at an early stage of tumor development led to augmentation of tumor-specific CTL as well as NK cell activities and to the resultant regression or growth inhibition of the tumors. On analysis of cytokine profile, gamma delta T cells transcribed mRNAs for IL-10 and TGF-beta, but not IL-4 or IFN-gamma, suggesting the T regulatory 1-like phenotype. Finally, a blocking study with mAbs showed that the inhibitory action of gamma delta T cells on CTLs and NK cells was at least partly mediated by IL-10 and TGF-beta. These results clearly demonstrated the novel mechanism by which T regulatory 1-like gamma delta T cells suppress anti-tumor CTL and NK activities by their regulatory cytokines in early tumor formation.
42
A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
Hervé Groux, Anne O’Garra, Mike Bigler et al. · Nature · 1997 · 3.6K citations
Life Sciences, Immunology, Pathology +12
Identification and induction of keratinocyte-derived IL-10
Alexander Enk, S I Katz · The Journal of Immunology · 1992 · 340 citations · Full text
Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism.
Lie Zheng, David M. Ojcius, F Garaud et al. · The Journal of Experimental Medicine · 1996 · 232 citations · Full text
Life Sciences, Immunology, Oncology +17
Shinichi Kondo, Makoto Asano, Katsuhiko Matsuo et al. · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · 1994 · 195 citations
Medicine, Immunology, Oncology +10